- Healthy male or female (of non-child bearing potential) subjects between 18 and 55
years of age.
- Body mass index of 17.5 to 30.5 kg/m2 and total body weight > 50kg.
- Evidence or history of any clinically significant disease.
- Treatment with an investigational drug within 30 days of study start
- Use of prescription and non-prescription medicines within 7 days of study start